# Diagnostic Robotics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/diagnostic-robotics

- Industry: Healthcare IT
- Headquarters: Tel Aviv-Yafo, Israel
- Website: www.diagnosticrobotics.com
- Total disclosed funding: $69M
- Latest round: Series B (Jul 25, 2022)
- Investors on record: 6

## About

Diagnostic Robotics Ltd. leverages artificial intelligence to streamline healthcare processes, enhancing operational efficiency and patient interactions through its innovative AI-powered platform, Maxine.Founded in 2017 and headquartered in Tel Aviv-Yafo, Israel, Diagnostic Robotics Ltd. focuses on developing AI solutions to improve healthcare efficiency. The company has undergone a business strategy pivot and secured funding as it expands its offerings. Kira Radinsky serves as the CEO. The firm raised USD 45 mn in a Series B funding round led by StageOne Ventures, with participation from Mayo Clinic on July 25, 2022, bringing the total amount raised to USD 45 mn.Diagnostic Robotics offers Maxine, an AI-powered solution that automates routine healthcare tasks and enhances patient interactions. This platform manages health plan use cases such as medication adherence and care transitions, streamlining communication among providers, payers, and patients, primarily targeting healthcare organizations in the United States.Diagnostic Robotics generates revenue through partnerships with healthcare organizations, utilizing a subscription model for Maxine's services. This model allows healthcare providers and health plans to engage directly with the platform, influencing pricing based on the volume of patients served. Maxine is integral to this revenue model, addressing multiple operational challenges in healthcare management.The recent Series B funding of USD 45 mn will be used to advance product development, expand marketing efforts, and grow the team. Diagnostic Robotics plans to enhance its product offerings and is actively targeting new markets to increase its reach in healthcare. The company aims to leverage its funding to facilitate these initiatives and expand its operational footprint.

## Funding rounds

- Series B, Jul 25, 2022, $45M — StageOne Ventures, Mayo Clinic
- Series A, Nov 13, 2019, $24M — Mivtach Shamir Holdings Ltd., Accelmed, Maverick Ventures Israel, Alpha Capital

## Investors

- Mivtach Shamir Holdings Ltd. — Series A
- Accelmed (https://capitalatlas.ai/funds/accelmed) — Series A
- Maverick Ventures Israel (https://capitalatlas.ai/funds/maverick-ventures-israel) — Series A
- Alpha Capital (https://capitalatlas.ai/funds/alpha-capital) — Series A
- StageOne Ventures (https://capitalatlas.ai/funds/stageone-ventures) — Series B
- Mayo Clinic — Series B